223 related articles for article (PubMed ID: 26839557)
1. Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review.
Faiella W; Atoui R
Stem Cells Int; 2016; 2016():1859567. PubMed ID: 26839557
[TBL] [Abstract][Full Text] [Related]
2. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
Haneef K; Ali A; Khan I; Naeem N; Jamall S; Salim A
Cardiovasc Ther; 2018 Dec; 36(6):e12479. PubMed ID: 30451388
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
[TBL] [Abstract][Full Text] [Related]
5. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction.
Lim M; Wang W; Liang L; Han ZB; Li Z; Geng J; Zhao M; Jia H; Feng J; Wei Z; Song B; Zhang J; Li J; Liu T; Wang F; Li T; Li J; Fang Y; Gao J; Han Z
Stem Cell Res Ther; 2018 May; 9(1):129. PubMed ID: 29751831
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.
Huang XP; Sun Z; Miyagi Y; McDonald Kinkaid H; Zhang L; Weisel RD; Li RK
Circulation; 2010 Dec; 122(23):2419-29. PubMed ID: 21098445
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic use of stem cells for cardiovascular disease.
Faiella W; Atoui R
Clin Transl Med; 2016 Dec; 5(1):34. PubMed ID: 27539581
[TBL] [Abstract][Full Text] [Related]
8. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction.
Nassiri SM; Khaki Z; Soleimani M; Ahmadi SH; Jahanzad I; Rabbani S; Sahebjam M; Ardalan FA; Fathollahi MS
J Biomed Sci; 2007 Nov; 14(6):745-55. PubMed ID: 17605008
[TBL] [Abstract][Full Text] [Related]
9. Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function.
Dhingra S; Li P; Huang XP; Guo J; Wu J; Mihic A; Li SH; Zang WF; Shen D; Weisel RD; Singal PK; Li RK
Circulation; 2013 Sep; 128(11 Suppl 1):S69-78. PubMed ID: 24030423
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction.
Chen L; Zhang Y; Tao L; Yang Z; Wang L
Cardiovasc Drugs Ther; 2017 Feb; 31(1):9-18. PubMed ID: 27913896
[TBL] [Abstract][Full Text] [Related]
11. [Mesenchymal stem cells: immunomodulatory properties and clinical application].
Golemović M; Skifić M; Cepulić BG
Lijec Vjesn; 2012; 134(1-2):42-9. PubMed ID: 22519252
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
[TBL] [Abstract][Full Text] [Related]
13. Regenerative capacity of intravenous autologous, allogeneic and human mesenchymal stem cells in the infarcted pig myocardium-complicated by myocardial tumor formation.
Wolf D; Reinhard A; Seckinger A; Gross L; Katus HA; Hansen A
Scand Cardiovasc J; 2009 Feb; 43(1):39-45. PubMed ID: 18609048
[TBL] [Abstract][Full Text] [Related]
14. Human placental stem cells: biomedical potential and clinical relevance.
Malek A; Bersinger NA
J Stem Cells; 2011; 6(2):75-92. PubMed ID: 22997848
[TBL] [Abstract][Full Text] [Related]
15. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
[TBL] [Abstract][Full Text] [Related]
16. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.
Ben Nasr M; Vergani A; Avruch J; Liu L; Kefaloyianni E; D'Addio F; Tezza S; Corradi D; Bassi R; Valderrama-Vasquez A; Usuelli V; Kim J; Azzi J; El Essawy B; Markmann J; Abdi R; Fiorina P
Acta Diabetol; 2015 Oct; 52(5):917-27. PubMed ID: 25808641
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-derived exosomes: A novel potential therapeutic avenue for cardiac regeneration.
Safari S; Malekvandfard F; Babashah S; Alizadehasl A; Sadeghizadeh M; Motavaf M
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):66-73. PubMed ID: 27453275
[TBL] [Abstract][Full Text] [Related]
18. Modification of mesenchymal stem cells for cardiac regeneration.
Song H; Song BW; Cha MJ; Choi IG; Hwang KC
Expert Opin Biol Ther; 2010 Mar; 10(3):309-19. PubMed ID: 20132054
[TBL] [Abstract][Full Text] [Related]
19. Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.
Majka M; Sułkowski M; Badyra B; Musiałek P
Stem Cells Transl Med; 2017 Oct; 6(10):1859-1867. PubMed ID: 28836732
[TBL] [Abstract][Full Text] [Related]
20. Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy.
Ludke A; Wu J; Nazari M; Hatta K; Shao Z; Li SH; Song H; Ni NC; Weisel RD; Li RK
J Mol Cell Cardiol; 2015 Jul; 84():116-28. PubMed ID: 25939780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]